Breye Therapeutics ApS — Credit Rating and Financial Key Figures

Breye Therapeutics ApS (CVR number: 40279865) is a company from RUDERSDAL. The company recorded a gross profit of -7545.6 kDKK in 2024. The operating profit was -82.6 mDKK, while net earnings were -89.1 mDKK. The profitability of the company measured by Return on Assets (ROA) was -103.9 %, which can be considered poor and Return on Equity (ROE) was -168.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -41.6 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Breye Therapeutics ApS's liquidity measured by quick ratio was 0.5 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.